hhs oig testifies on the 340b drug pricing program
Published 9 years ago • 1.2K plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
4:26
oig-hhs testifies on oig’s oversight of the affordable care act
-
4:42
hhs-oig testifies on healthcare.gov: a review of operations and enrollment
-
4:11
hhs oig testifies about medicare fraud
-
4:18
hhs oig testifies on continuing concerns with the federal select agent program
-
2:32:26
examining hrsa’s oversight of the 340b drug pricing program
-
3:59
hhs-oig testifies on medicaid and chip's federal medical assistance percentage
-
5:05
hospital 340b drug program explained
-
5:47
ashp testifies during senate hearing on 340b drug pricing program
-
10:12
hd-b604-s universal testing machine
-
38:15
introduction to covered entities and the 340b drug pricing program - burrows consulting
-
6:30
understanding the 340b drug pricing program
-
2:25:08
examining how covered entities utilize the 340b drug pricing program
-
1:50
dr peter bach examines the problems of the 340b drug pricing program
-
5:07
influence of the 340b drug pricing program
-
1:09
who benefits from the 340b drug discount program?
-
1:37
perspectives on the 340b drug discount program
-
2:09
340b drug pricing program: what regulatory and legislative changes are on the horizon?
-
5:09
bilirakis questions witnesses regarding the 340b drug program
-
2:24
the 340b safety-net program is failing many vulnerable patients
-
1:07
aha protect 340b drug pricing program
-
2:49
what is the 340b drug pricing program and how does it work?
-
1:08
hhs-oig 2021 year in review